Johnson & Johnson (NYSE: JNJ) stock first traded back in 1944. For the first 58 years of the company's existence, it was privately held by the Johnson family. J&J stock has been a big winner throughout the years, but never more so …
Drugmaker Johnson & Johnson (NYSE: JNJ) announced a $10 billion stock buyback program today (Tuesday) amid a mixed Q3 earnings report. The $10 billion JNJ stock buyback represents about 3.7% of the company's outstanding …
If you're looking for a textbook example of a steady rise in shares, it doesn't get much better than the current Johnson & Johnson stock run-up. Shares in the blue-chip company are up 15% year-to-date with a nice upward trend. JNJ data …
JNJ Stock a Top Dividend Name for 2016 and Beyond Johnson 38; Johnson (NYSE:JNJ) is an old stalwart, known for being one of the most reliable stocks for dividend investors. It is among an elite class of companies that have increased …
Out to strengthen its pipeline of new drugs, Johnson & Johnson announced yesterday that it would buy Centocor Inc., one of the nation's largest biotechnology companies, for $4.9 billion in stock. The acquisition is part of a rapidly growing …
Tyler Durden: Perhaps the only chart more troubling than Johnson & Johnson’s (NYSE:JNJ) stock price in 2015, …
SOMERVILLE, N.J., Aug. 23-- Johnson and Johnson issued the following news release: Spectrum Health realized …
JNJ reported Q3 earnings last month ... those repurchased shares would have otherwise received. The stock also trades at about 15x earnings, net of excess cash on the balance sheet – an ostensibly fair price to pay. Perhaps this was also a …
At Johnson & Johnson, the world’s largest health care company ... J&J’s 2014 profit forecast was slightly lower than analysts’ expectations, which sent the stock down 2.6 percent on Wall Street, before climbing back up. It finished the …